10-Q Filing

LIFECORE BIOMEDICAL, INC. DE CIK: 1005286 Q2 2014

Filing Information

Form Type	10-Q
Accession Number	`0001437749-14-000124`
Period End Date	20131130
Filing Date	20140103
Fiscal Year	2014
Fiscal Period	Q2
XBRL Instance	lndc-20131124.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 98 Cash Flow Statement 75

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$583.00K	USD	Point-in-time
Allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$430.00K	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.77M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$22.18M	USD	Point-in-time
Common stock, shares authorized (in Shares)	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Common stock, shares authorized (in Shares)	`CommonStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.86M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$13.72M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$1.54M	USD	Point-in-time
Common stock, shares issued (in Shares)	`CommonStockSharesIssued`	26.65M	shares	Point-in-time
Common stock, shares issued (in Shares)	`CommonStockSharesIssued`	26.40M	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $430 and $583 at November 24, 2013 and May 26, 2013, respectively	`AccountsReceivableNetCurrent`	$41.74M	USD	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $430 and $583 at November 24, 2013 and May 26, 2013, respectively	`AccountsReceivableNetCurrent`	$36.07M	USD	Point-in-time
Common stock, shares outstanding (in Shares)	`CommonStockSharesOutstanding`	26.40M	shares	Point-in-time
Common stock, shares outstanding (in Shares)	`CommonStockSharesOutstanding`	26.65M	shares	Point-in-time
Accounts receivable, related party	`AccountsReceivableRelatedPartiesCurrent`	$131.00K	USD	Point-in-time
Accounts receivable, related party	`AccountsReceivableRelatedPartiesCurrent`	$671.00K	USD	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	$5.10M	USD	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	$5.02M	USD	Point-in-time
Inventories, net	`InventoryNet`	$24.11M	USD	Point-in-time
Inventories, net	`InventoryNet`	$26.86M	USD	Point-in-time
Deferred taxes	`DeferredTaxAssetsNetCurrent`	$1.80M	USD	Point-in-time
Deferred taxes	`DeferredTaxAssetsNetCurrent`	$1.58M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.22M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.86M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$85.54M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$85.66M	USD	Point-in-time
Investment in non-public company, non-fair value	`CostMethodInvestments`	$793.00K	USD	Point-in-time
Investment in non-public company, non-fair value	`CostMethodInvestments`	$793.00K	USD	Point-in-time
Investment in non-public company, fair value	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue`	$29.60M	USD	Point-in-time
Investment in non-public company, fair value	`FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue`	$37.30M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$70.02M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$65.81M	USD	Point-in-time
Goodwill, net	`Goodwill`	$49.62M	USD	Point-in-time
Goodwill, net	`Goodwill`	$13.16M	USD	Point-in-time
Goodwill, net	`Goodwill`	$49.62M	USD	Point-in-time
Trademarks/tradenames, net	`IndefiniteLivedTrademarks`	$48.43M	USD	Point-in-time
Trademarks/tradenames, net	`IndefiniteLivedTrademarks`	$48.43M	USD	Point-in-time
Customer relationships, net	`FiniteLivedCustomerListsNet`	$9.61M	USD	Point-in-time
Customer relationships, net	`FiniteLivedCustomerListsNet`	$9.16M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.39M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.42M	USD	Point-in-time
Total Assets	`Assets`	$290.94M	USD	Point-in-time
Total Assets	`Assets`	$302.26M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$31.47M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$34.52M	USD	Point-in-time
Related party accounts payable	`AccountsPayableRelatedPartiesCurrent`	$242.00K	USD	Point-in-time
Related party accounts payable	`AccountsPayableRelatedPartiesCurrent`	$786.00K	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$4.98M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$3.31M	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$2.33M	USD	Point-in-time
Other accrued liabilities	`OtherAccruedLiabilitiesCurrent`	$4.51M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$1.28M	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$1.25M	USD	Point-in-time
Lines of credit	`LinesOfCreditCurrent`	$1.00M	USD	Point-in-time
Lines of credit	`LinesOfCreditCurrent`	$4.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$5.93M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$5.99M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$50.85M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$50.75M	USD	Point-in-time
Long-term debt, less current portion	`LongTermDebtNoncurrent`	$31.19M	USD	Point-in-time
Long-term debt, less current portion	`LongTermDebtNoncurrent`	$34.37M	USD	Point-in-time
Deferred taxes	`DeferredTaxLiabilitiesNoncurrent`	$28.32M	USD	Point-in-time
Deferred taxes	`DeferredTaxLiabilitiesNoncurrent`	$24.05M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.35M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$1.62M	USD	Point-in-time
Total Liabilities	`Liabilities`	$110.53M	USD	Point-in-time
Total Liabilities	`Liabilities`	$111.99M	USD	Point-in-time
Common stock, $0.001 par value; 50,000,000 shares authorized; 26,650,586 and 26,402,247 shares issued and outstanding at November 24, 2013 and May 26, 2013, respectively	`CommonStockValue`	$26.00K	USD	Point-in-time
Common stock, $0.001 par value; 50,000,000 shares authorized; 26,650,586 and 26,402,247 shares issued and outstanding at November 24, 2013 and May 26, 2013, respectively	`CommonStockValue`	$27.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$126.26M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$128.03M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$60.61M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$52.41M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$188.67M	USD	Point-in-time
Total Stockholders Equity	`StockholdersEquity`	$178.69M	USD	Point-in-time
Non controlling interest	`MinorityInterest`	$1.72M	USD	Point-in-time
Non controlling interest	`MinorityInterest`	$1.60M	USD	Point-in-time
Total Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$190.27M	USD	Point-in-time
Total Equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$180.41M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$302.26M	USD	Point-in-time
Total Liabilities and Stockholders Equity	`LiabilitiesAndStockholdersEquity`	$290.94M	USD	Point-in-time

Income Statement 98 line items

Line Item	Tag	Value	Unit	Period
Product sales	`SalesRevenueGoodsNet`	$114.09M	USD	1 Quarter
Product sales	`SalesRevenueGoodsNet`	$215.39M	USD	2 Qtrs
Product sales	`SalesRevenueGoodsNet`	$119.55M	USD	1 Quarter
Product sales	`SalesRevenueGoodsNet`	$228.48M	USD	2 Qtrs
Services revenue, related party	`RevenueFromRelatedParties`	$475.00K	USD	1 Quarter
Services revenue, related party	`RevenueFromRelatedParties`	$1.33M	USD	2 Qtrs
Services revenue, related party	`RevenueFromRelatedParties`	$1.02M	USD	2 Qtrs
Services revenue, related party	`RevenueFromRelatedParties`	$563.00K	USD	1 Quarter
Total revenues	`Revenues`	$114.65M	USD	1 Quarter
Total revenues	`Revenues`	$120.03M	USD	1 Quarter
Total revenues	`Revenues`	$216.73M	USD	2 Qtrs
Total revenues	`Revenues`	$229.50M	USD	2 Qtrs
Cost of product sales	`CostOfGoodsSold`	$105.89M	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$202.32M	USD	2 Qtrs
Cost of product sales	`CostOfGoodsSold`	$95.71M	USD	1 Quarter
Cost of product sales	`CostOfGoodsSold`	$183.37M	USD	2 Qtrs
Cost of services revenue	`CostOfServices`	$919.00K	USD	2 Qtrs
Cost of services revenue	`CostOfServices`	$1.14M	USD	2 Qtrs
Cost of services revenue	`CostOfServices`	$402.00K	USD	1 Quarter
Cost of services revenue	`CostOfServices`	$488.00K	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$203.24M	USD	2 Qtrs
Total cost of revenue	`CostOfRevenue`	$106.29M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$96.19M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$184.51M	USD	2 Qtrs
Gross profit	`GrossProfit`	$13.73M	USD	1 Quarter
Gross profit	`GrossProfit`	$26.27M	USD	2 Qtrs
Gross profit	`GrossProfit`	$32.22M	USD	2 Qtrs
Gross profit	`GrossProfit`	$18.46M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.85M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.92M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.11M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.32M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$17.74M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$8.64M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$17.27M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$9.19M	USD	1 Quarter
Change in value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-3.93M	USD	1 Quarter
Change in value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-3.93M	USD	2 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$10.56M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$21.11M	USD	2 Qtrs
Total operating costs and expenses	`OperatingExpenses`	$7.37M	USD	1 Quarter
Total operating costs and expenses	`OperatingExpenses`	$18.13M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$11.09M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$14.10M	USD	2 Qtrs
Operating income	`OperatingIncomeLoss`	$3.18M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$5.15M	USD	2 Qtrs
Dividend income	`InvestmentIncomeDividend`	$281.00K	USD	1 Quarter
Dividend income	`InvestmentIncomeDividend`	$563.00K	USD	2 Qtrs
Dividend income	`InvestmentIncomeDividend`	$563.00K	USD	2 Qtrs
Dividend income	`InvestmentIncomeDividend`	$281.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$46.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$58.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$105.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$33.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$498.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$436.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$867.00K	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.04M	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$983.00K	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$2.30M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$7.70M	USD	2 Qtrs
Other income	`OtherNonoperatingIncomeExpense`	$5.24M	USD	2 Qtrs
Net income before taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$5.37M	USD	1 Quarter
Net income before taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$11.89M	USD	1 Quarter
Net income before taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$12.65M	USD	2 Qtrs
Net income before taxes	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$18.92M	USD	2 Qtrs
Income tax expense	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax`	$2.92M	USD	1 Quarter
Income tax expense	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax`	$5.48M	USD	2 Qtrs
Income tax expense	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax`	$1.87M	USD	1 Quarter
Income tax expense	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax`	$4.35M	USD	2 Qtrs
Consolidated net income	`ProfitLoss`	$3.49M	USD	1 Quarter
Consolidated net income	`ProfitLoss`	$8.97M	USD	1 Quarter
Consolidated net income	`ProfitLoss`	$8.30M	USD	2 Qtrs
Consolidated net income	`ProfitLoss`	$13.44M	USD	2 Qtrs
Non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$156.00K	USD	2 Qtrs
Non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$101.00K	USD	2 Qtrs
Non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$59.00K	USD	1 Quarter
Non controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$42.00K	USD	1 Quarter
Net income and comprehensive income applicable to common stockholders	`ComprehensiveIncomeNetOfTax`	$8.20M	USD	2 Qtrs
Net income and comprehensive income applicable to common stockholders	`ComprehensiveIncomeNetOfTax`	$3.45M	USD	1 Quarter
Net income and comprehensive income applicable to common stockholders	`ComprehensiveIncomeNetOfTax`	$13.28M	USD	2 Qtrs
Net income and comprehensive income applicable to common stockholders	`ComprehensiveIncomeNetOfTax`	$8.91M	USD	1 Quarter
Basic net income per share (in Dollars per share)	`EarningsPerShareBasic`	$0.35	USD	1 Quarter
Basic net income per share (in Dollars per share)	`EarningsPerShareBasic`	$0.31	USD	2 Qtrs
Basic net income per share (in Dollars per share)	`EarningsPerShareBasic`	$0.13	USD	1 Quarter
Basic net income per share (in Dollars per share)	`EarningsPerShareBasic`	$0.52	USD	2 Qtrs
Diluted net income per share (in Dollars per share)	`EarningsPerShareDiluted`	$0.34	USD	1 Quarter
Diluted net income per share (in Dollars per share)	`EarningsPerShareDiluted`	$0.50	USD	2 Qtrs
Diluted net income per share (in Dollars per share)	`EarningsPerShareDiluted`	$0.13	USD	1 Quarter
Diluted net income per share (in Dollars per share)	`EarningsPerShareDiluted`	$0.30	USD	2 Qtrs
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	25.75M	shares	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	26.57M	shares	1 Quarter
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	26.51M	shares	2 Qtrs
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	25.71M	shares	2 Qtrs
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	26.39M	shares	2 Qtrs
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	27.08M	shares	2 Qtrs
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	26.54M	shares	1 Quarter
Diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	27.07M	shares	1 Quarter

Cash Flow Statement 75 line items

Line Item	Tag	Value	Unit	Period
Consolidated net income	`ProfitLoss`	$3.49M	USD	1 Quarter
Consolidated net income	`ProfitLoss`	$8.97M	USD	1 Quarter
Consolidated net income	`ProfitLoss`	$8.30M	USD	2 Qtrs
Consolidated net income	`ProfitLoss`	$13.44M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.66M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.79M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$323.00K	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$671.00K	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$639.00K	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$361.00K	USD	1 Quarter
Tax benefit from stock-based compensation expense	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$1.81M	USD	2 Qtrs
Tax benefit from stock-based compensation expense	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$175.00K	USD	2 Qtrs
Loss on disposal of property and equipment	`GainLossOnDispositionOfAssets`	$-124.00K	USD	2 Qtrs
Loss on disposal of property and equipment	`GainLossOnDispositionOfAssets`	$-180.00K	USD	2 Qtrs
Deferred taxes	`DeferredIncomeTaxExpenseBenefit`	$4.05M	USD	2 Qtrs
Deferred taxes	`DeferredIncomeTaxExpenseBenefit`	$3.04M	USD	2 Qtrs
Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-3.93M	USD	1 Quarter
Contingent Consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$-3.93M	USD	2 Qtrs
Change in investment in non-public company (fair market value)	`FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss`	$5.25M	USD	2 Qtrs
Change in investment in non-public company (fair market value)	`FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss`	$7.70M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInReceivables`	$8.64M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInReceivables`	$5.67M	USD	2 Qtrs
Accounts receivable, related party	`IncreaseDecreaseInDueFromRelatedParties`	$-10.00K	USD	2 Qtrs
Accounts receivable, related party	`IncreaseDecreaseInDueFromRelatedParties`	$-540.00K	USD	2 Qtrs
Income taxes receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$-262.00K	USD	2 Qtrs
Income taxes receivable	`IncreaseDecreaseInIncomeTaxesReceivable`	$-1.84M	USD	2 Qtrs
Inventories, net	`IncreaseDecreaseInInventories`	$2.39M	USD	2 Qtrs
Inventories, net	`IncreaseDecreaseInInventories`	$2.75M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$1.36M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$436.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.05M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.30M	USD	2 Qtrs
Related party accounts payable	`IncreaseDecreaseInAccountsPayableRelatedParties`	$-351.00K	USD	2 Qtrs
Related party accounts payable	`IncreaseDecreaseInAccountsPayableRelatedParties`	$-544.00K	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-1.22M	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-743.00K	USD	2 Qtrs
Other accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-616.00K	USD	2 Qtrs
Other accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$2.45M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$34.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$908.00K	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.38M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.29M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.68M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.28M	USD	2 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$2.46M	USD	2 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$1.42M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-6.14M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-5.24M	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.25M	USD	2 Qtrs
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$651.00K	USD	2 Qtrs
Taxes paid by Company for stock swaps and RSUs	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.22M	USD	2 Qtrs
Taxes paid by Company for stock swaps and RSUs	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$49.00K	USD	2 Qtrs
Tax benefit from stock-based compensation expense	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$175.00K	USD	2 Qtrs
Tax benefit from stock-based compensation expense	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$1.81M	USD	2 Qtrs
Earn out payment from Lifecore acquisition	`EarnOutPaymentFromAcquisition`	$9.65M	USD	2 Qtrs
Payments on long-term debt	`RepaymentsOfLongTermDebt`	$3.09M	USD	2 Qtrs
Payments on long-term debt	`RepaymentsOfLongTermDebt`	$3.13M	USD	2 Qtrs
Payments on lines of credit	`RepaymentsOfLinesOfCredit`	$3.00M	USD	2 Qtrs
Payments on lines of credit	`RepaymentsOfLinesOfCredit`	$4.17M	USD	2 Qtrs
Decrease in other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-345.00K	USD	2 Qtrs
Decrease in other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-36.00K	USD	2 Qtrs
Payments to minority interest holders	`PaymentsToMinorityShareholders`	$226.00K	USD	2 Qtrs
Payments to minority interest holders	`PaymentsToMinorityShareholders`	$321.00K	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-14.47M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-6.11M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-17.32M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-7.95M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.77M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$22.18M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.86M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$13.72M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.77M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$22.18M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$4.86M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$13.72M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.